Hui Long
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- Gut microbiota and health 3
- Circular RNAs in diseases 3
- Surgery 17
- Intraperitoneal and Appendiceal Malignancies 9
- Helicobacter pylori-related gastroenterology studies 3
- Co-authors
- Qingming Wu (14 shared papers)Hongwei Ren (3 shared papers)Huan Li (2 shared papers)Xiaochen Xiang (2 shared papers)Shuzhong Cui (14 shared papers)Mingchen Ba (15 shared papers)Qiang Wang (6 shared papers)Yuanfeng Gong (10 shared papers)
- Journals
- Bone Marrow Transplantation (2 papers)Oncotarget (2 papers)Fitoterapia (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)BioMed Research International (2 papers)
- Partner nations
- ChinaUnited StatesBelarus
In The Last Decade
Hui Long
63 papers receiving 1.7k citations
Hui Long's Hit Papers
Peers
Comparison fields: 5 of 139
- Infectious Diseases 508
- Neurology 183
- Hematology 127
- Cancer Research 146
- Oncology 158
Countries citing papers authored by Hui Long
This map shows the geographic impact of Hui Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Long more than expected).
Fields of papers citing papers by Hui Long
This network shows the impact of papers produced by Hui Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Long. The network helps show where Hui Long may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Long, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China Hit paper breakdown → | 2020 | 300 |
| 2 | 2020 | 176 | |
| 3 | 2020 | 143 | |
| 4 | 2020 | 111 | |
| 5 | 2022 | 79 | |
| 6 | 2021 | 77 | |
| 7 | 1959 | 74 | |
| 8 | 2017 | 64 | |
| 9 | 2012 | 53 | |
| 10 | 2001 | 48 | |
| 11 | 2016 | 47 | |
| 12 | GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review. | 2012 | 40 |
| 13 | 2017 | 37 | |
| 14 | 2020 | 34 | |
| 15 | 2021 | 32 | |
| 16 | 2022 | 31 | |
| 17 | 2023 | 25 | |
| 18 | 2022 | 21 | |
| 19 | 2013 | 21 | |
| 20 | 2022 | 21 |
About Hui Long
Hui Long is a scholar working on Molecular Biology, Surgery, Hematology, Oncology and Epidemiology, having authored 66 papers that have together received 1.7k indexed citations. Recurring topics across this work include Intraperitoneal and Appendiceal Malignancies (9 papers), Hematopoietic Stem Cell Transplantation (3 papers), Gut microbiota and health (3 papers), Helicobacter pylori-related gastroenterology studies (3 papers), COVID-19 Clinical Research Studies (3 papers), Autophagy in Disease and Therapy (3 papers), Cancer-related molecular mechanisms research (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Infectious Diseases (508 citations), Neurology (183 citations), Hematology (127 citations), Cancer Research (146 citations) and Oncology (158 citations). Hui Long has collaborated with scholars based in China, United States and Belarus. Frequent co-authors include Qingming Wu, Hongwei Ren, Huan Li, Xiaochen Xiang, Shuzhong Cui, Mingchen Ba, Qiang Wang, Yuanfeng Gong, Youping Deng and Yi Zuo. Their work appears in journals such as Bone Marrow Transplantation, Oncotarget, Fitoterapia, Journal of Cancer Research and Clinical Oncology and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.